A114G (p.Ala114Gly) variant of ABL2 (Tyrosine-protein kinase ABL2)
A114G (p.Ala114Gly) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes population frequency data.
A114G (p.Ala114Gly) variant details
- p.Ala114Gly
- TOPMed rs1028542505
- gnomAD rs1028542505
- Missense
- Variant Prioritization Score for Impact Estimate 0.771
- REVEL 0.77
- CADD 26.30
- PolyPhen-2 0.63
- SIFT 0.01
- Population evidence available